Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of modulating ribonucleotide reductase

Method of modulating ribonucleotide reductase

US Patent 11439623 · Granted Sep 13, 2022

Estimated economic value: $243,170,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of modulating ribonucleotide reductase2024
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and h2019
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and h2018
Method of modulating ribonucleotide reductase2018
Anti-virulance compositions and methods2017
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and h2017
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and h2017
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and h2016
Pyrazolopyridazines and methods for treating retinal degenerative diseases and h2016
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and h2016
Pyro-glutamate Aβ targeting agents2015
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and h2015